Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor

Biochemical Journal

Volumn 433, Issue 1, 2011, Pages 235-244

  Choi, Kyung Chul ^a   Park, SiYong ^b   Lim, Beom Jin ^c   Sung, Ah Reum ^a   Lee, Yoo Hyun ^d   Shiota, Masaki ^e   Yokomizo, Akira ^e   Naito, Seiji ^e   Na, Younghwa ^f   Yoon, Ho Geun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Suwon University   (South Korea)

^e KYUSHU UNIVERSITY   (Japan)

^f Catholic University of Daegu   (South Korea)

Author keywords

Acetylation; Androgen receptor; Histone acetyltransferase; Procyanidin b3; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; FLUTAMIDE; HISTONE ACETYLTRANSFERASE; PROCYANIDIN B3; PROCYANIDIN DERIVATIVE; PROTEIN P300; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; TRANSCRIPTION INITIATION;

ACETYLATION; BIFLAVONOIDS; CATECHIN; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; E1A-ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASES; HUMANS; MALE; PROANTHOCYANIDINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 79551473225     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20100980     Document Type: Article

References (31)

1. Culig, Z., Klocker, H., Bartsch, G., Steiner, H. and Hobisch, A. (2003) Androgen receptors in prostate cancer. J. Urol. 170, 1363-1369
2. Faus, H. and Haendler, B. (2008) Androgen receptor acetylation sites differentially regulate gene control. J. Cell. Biochem. 104, 511-524
3. Kaikkonen, S., Jaaskelainen, T., Karvonen, U., Rytinki, M. M., Makkonen, H., Gioeli, D., Paschal, B. M. and Palvimo, J. J. (2009) SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol. Endocrinol. 23, 292-307
4. Kuiper, G. G., De Ruiter, P. E. and Brinkmann, A. O. (1993) Androgen receptor phosphorylation. Ann. N. Y. Acad. Sci. 684, 224-226
5. Lin, H. K., Wang, L., Hu, Y. C., Altuwaijri, S. and Chang, C. (2002) Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21, 4037-4048
6. Fu, M., Wang, C., Wang, J., Zhang, X., Sakamaki, T., Yeung, Y. G., Chang, C., Hopp, T., Fuqua, S. A., Jaffray, E. et al. (2002) Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol. Cell. Biol. 22, 3373-3388
7. Shiota, M., Yokomizo, A., Masubuchi, D., Tada, Y., Inokuchi, J., Eto, M., Uchiumi, T., Fujimoto, N. and Naito, S. (2010) Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. Prostate 70, 540-554
8. Halkidou, K., Gnanapragasam, V. J., Mehta, P. B., Logan, I. R., Brady, M. E., Cook, S., Leung, H. Y., Neal, D. E. and Robson, C. N. (2003) Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22, 2466-2477
9. Fu, M., Rao, M., Wang, C., Sakamaki, T., Wang, J., Di Vizio, D., Zhang, X., Albanese, C., Balk, S., Chang, C. et al. (2003) Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol. Cell. Biol. 23, 8563-8575
10. Balasubramanyam, K., Altaf, M., Varier, R. A., Swaminathan, V., Ravindran, A., Sadhale, P. P. and Kundu, T. K. (2004) Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279, 33716-33726
11. Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U. and Kundu, T. K. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163-51171
12. Choi, K. C., Jung, M. G., Lee, Y. H., Yoon, J. C., Kwon, S. H., Kang, H. B., Kim, M. J., Cha, J. H., Kim, Y. J., Jun, W. J. et al. (2009) Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 69, 583-592
13. Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M. and Aggarwal, B. B. (2008) Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis. Blood 111, 4880-4891
14. Isharwal, S., Miller, M. C., Marlow, C., Makarov, D. V., Partin, A. W. and Veltri, R. W. (2008) p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. Prostate 68, 1097-1104
15. Iyer, N. G., Ozdag, H. and Caldas, C. (2004) p300/CBP and cancer. Oncogene 23, 4225-4231
16. Khanal, R. C., Howard, L. R. and Prior, R. L. (2009) Procyanidin content of grape seed and pomace, and total anthocyanin content of grape pomace as affected by extrusion processing. J. Food Sci. 74, H174-H182
17. 1 arrest and apoptosis. Mol. Carcinog. 28, 129-138
18. Zhao, J., Wang, J., Chen, Y. and Agarwal, R. (1999) Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 20, 1737-1745
19. Kaur, M., Singh, R. P., Gu, M., Agarwal, R. and Agarwal, C. (2006) Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin. Cancer Res. 12, 6194-6202
20. Eng, E. T., Ye, J., Williams, D., Phung, S., Moore, R. E., Young, M. K., Gruntmanis, U., Braunstein, G. and Chen, S. (2003) Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res. 63, 8516-8522
21. Yoon, H. G. and Wong, J. (2006) The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol. Endocrinol. 20, 1048-1060
22. Dignam, J. D., Lebovitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
23. Choi, K. C., Lee, Y. H., Jung, M. G., Kwon, S. H., Kim, M. J., Jun, W. J., Lee, J., Lee, J. M. and Yoon, H. G. (2009) Gallic acid suppresses lipopolysaccharide-induced nuclear factor-κB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol. Cancer Res. 7, 2011-2021
24. Glozak, M. A., Sengupta, N., Zhang, X. and Seto, E. (2005) Acetylation and deacetylation of non-histone proteins. Gene 363, 15-23
25. Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M. L. and Pestell, R. G. (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 275, 20853-20860
26. Schellhammer, P. F., Sharifi, R., Block, N. L., Soloway, M. S., Venner, P. M., Patterson, A. L., Sarosdy, M. F., Vogelzang, N. J., Chen, Y. and Kolvenbag, G. J. (1996) A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group. Cancer 78, 2164-2169
27. Klotz, L. (2000) Hormone therapy for patients with prostate carcinoma. Cancer 88, 3009-3014
28. Sathya, G., Chang, C. Y., Kazmin, D., Cook, C. E. and McDonnell, D. P. (2003) Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. Cancer Res. 63, 8029-8036
29. Dotzlaw, H., Papaioannou, M., Moehren, U., Claessens, F. and Baniahmad, A. (2003) Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. Mol. Cell. Endocrinol. 213, 79-85
30. Lee, Y. H., Jung, M. G., Kang, H. B., Choi, K. C., Haam, S., Jun, W., Kim, Y. J., Cho, H. Y. and Yoon, H. G. (2008) Effect of anti-histone acetyltransferase activity from Rosa rugosa Thunb. (Rosaceae) extracts on androgen receptor-mediated transcriptional regulation. J. Ethnopharmacol. 118, 412-417
31. Lee, Y. H., Hong, S. W., Jun, W., Cho, H. Y., Kim, H. C., Jung, M. G., Wong, J., Kim, H. I., Kim, C. H. and Yoon, H. G. (2007) Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth. Biosci. Biotechnol. Biochem. 71, 2712-2719